Spravato (Esketamine) therapy utilizes low doses of Esketamine, an FDA-approved medication designed to alleviate the treatment-resistant major depressive disorder. While high doses are used in surgery, the “sub-anesthetic” doses in our therapy are employed to enhance mood, cognition, and pain perception through unique mechanisms.
How Does Spravato (Esketamine) Therapy Work?
By inhibiting the NMDA receptor, esketamine swiftly alleviates symptoms, promoting rapid and lasting relief from depression and other mental health issues.
What is SPRAVATO®?
SPRAVATO® is an FDA approved breakthrough treatment using esketamine, a derivative of ketamine, administered via nasal spray. Mercyland Psychiatry is one of the few accredited treatment centers for the administration of Spravato,
This treatment works by affecting glutamate pathways, offering a new hope for those who have not benefited from traditional therapies.
It is primarily prescribed to adults whose condition has not been improved with use of antidepressants. These treatments require prolonged monitoring in a clinical setting.
